Northern Trust’s Oragenics OGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGEN
TRCT
IA
WWM
Northern Trust's OGEN Position: Q1 2023 in Review
Northern Trust sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 101 shares — an estimated $19.1K sold.
Northern Trust first reported a position in OGEN in Q3 2015 and held it in 26 quarters. The position peaked at $165K in Q1 2021. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.
- Northern Trust reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
- Northern Trust sold 101 Oragenics shares in Q1 2023, an estimated $19.1K.
- Northern Trust first reported a position in Oragenics in Q3 2015 and held it in 26 quarters.
- Northern Trust's Oragenics position peaked at $165K in Q1 2021.
- 10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.
Based on Northern Trust's 13F filing for Q1 2023, filed 15 May 2023.